SCHEMBL6205148

SCHEMBL6205148

COC([O])c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.44
SLC6A4 P31645 2/20 0.44
AOC3 Q16853 1/20 0.44
ALOX15 P16050 1/20 0.43
BRD4 O60885 1/20 0.42
IDO1 P14902 3/20 0.41
TDO2 P48775 3/20 0.41
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
HIF1A Q16665 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CNR2 P34972 1/20 0.40
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
CYP2A6 P11509 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
SLC6A2 P23975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203867 0.78 CHRNA7 (0.41) TSHRTDP1CNR2
SCHEMBL6202338 0.78 CYP1A2 (0.43) MAPK1LMNAHPGDCYP2A6MAPT
SCHEMBL6205144 0.76 TSHR (0.38) AOC3IDO1TDO2TSHRCNR2
SCHEMBL6206390 0.76 AOC3 (0.44) SLC6A4AOC3IDO1TDO2LMNA
SCHEMBL6205817 0.76 CA1 (0.52) AOC3TSHRMAPK1TDP1CYP2A6
SCHEMBL6203511 0.76 SLC6A2 (0.49) SLC6A4IDO1TDO2LMNASLC6A2
SCHEMBL28752762 0.76 SLC6A2 (0.43) SLC6A4TSHRMAPK1SLC6A2SLC6A3
SCHEMBL83160 0.75 KMT2A (0.46) IDO1TDO2TSHRHPGD
SCHEMBL791590 0.75 IDO1 (0.56) ADRB2SLC6A4AOC3ALOX15BRD4
SCHEMBL654510 0.75 ADRB2 (0.48) ADRB2SLC6A4AOC3ALOX15BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1668601-A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors JANSSEN PHARMACEUTICA NV (BE) 2005-09-14 CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed